BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.
Saved in:
| Title: | BCL3 expression promotes resistance to alkylating chemotherapy in gliomas. |
|---|---|
| Authors: | Wu L; Section of Neurosurgery, Department of Surgery, University of Chicago, Chicago, IL 60637, USA., Bernal GM; Section of Neurosurgery, Department of Surgery, University of Chicago, Chicago, IL 60637, USA., Cahill KE; Section of Neurosurgery, Department of Surgery, University of Chicago, Chicago, IL 60637, USA., Pytel P; Department of Pathology, University of Chicago, Chicago, IL 60637, USA., Fitzpatrick CA; Department of Pathology, University of Chicago, Chicago, IL 60637, USA., Mashek H; Department of Pathology, University of Chicago, Chicago, IL 60637, USA., Weichselbaum RR; Department of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA., Yamini B; Section of Neurosurgery, Department of Surgery, University of Chicago, Chicago, IL 60637, USA. byamini@surgery.bsd.uchicago.edu. |
| Source: | Science translational medicine [Sci Transl Med] 2018 Jul 04; Vol. 10 (448). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
